The total return over the past 12 months is +70.56% vs. +16.94% for the S&P 500. So far it's up -1.44% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +70.56% | +41.25% | +2.88% | N/A | N/A | N/A |
| Total Return CAGR | +70.56% | +41.25% | +2.88% | N/A | N/A | N/A |
| Revenue CAGR | (100.00%) | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Immunome, Inc. (IMNM)
| Year | Start price | End price | IMNM Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $21.48 | $21.17 | (1.44%) | +14.51% | (15.95%) |
| 2025 | $10.62 | $21.48 | +102.26% | +17.72% | +84.54% |
| 2024 | $10.70 | $10.62 | (0.75%) | +24.89% | (25.64%) |
| 2023 | $2.21 | $10.70 | +384.16% | +26.19% | +357.97% |
| 2022 | $12.96 | $2.21 | (82.95%) | (18.17%) | (64.78%) |
| 2021 | $9.68 | $12.96 | +33.88% | +28.74% | +5.14% |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
